A Novel Histone Deacetylase Inhibitor, Scriptaid, Enhances Expression of Functional Estrogen Receptor α (ER) in ER negative human breast cancer cells in combination with 5-aza 2′-deoxycytidine
- 1 October 2003
- journal article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 81 (3) , 177-186
- https://doi.org/10.1023/a:1026146524737
Abstract
Epigenetic mechanisms, such as DNA methylation and histone deacetylation, may play a role in loss of estrogen receptor α (ER) expression in ER negative human breast cancer cells. Our previous studies...Keywords
This publication has 17 references indexed in Scilit:
- The Interaction of Histone Deacetylase Inhibitors and DNA Methyltransferase Inhibitors in the Treatment of Human Cancer CellsCurrent Medicinal Chemistry - Anti-Cancer Agents, 2003
- The biology of breast carcinomaCancer, 2003
- Worms gang up on bacteriaNature Reviews Genetics, 2002
- Altered methylation patterns in cancer cell genomes: Cause or consequence?Cancer Cell, 2002
- Methylation Talk Between Histones and DNAScience, 2001
- Antineoplastic action of 5-aza-2′-deoxycytidine and histone deacetylase inhibitor and their effect on the expression of retinoic acid receptor β and estrogen receptor α genes in breast carcinoma cellsCancer Chemotherapy and Pharmacology, 2001
- Introduction: Epigenetics and Breast CancerJournal of Mammary Gland Biology and Neoplasia, 2001
- Methylation-Induced Repression— Belts, Braces, and ChromatinPublished by Elsevier ,1999
- DNA methylation analysis at distal and proximal promoter regions of the oestrogen receptor gene in breast cancersBritish Journal of Cancer, 1999
- Synergy of demethylation and histone deacetylase inhibition in the re-expression of genes silenced in cancerNature Genetics, 1999